Phase 3 Neurogenic Bladder Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder
Neurogenic Bladder
Centre Hospitalier Universitaire Dijon110 enrolled1 locationNCT06588010
Recruiting
Phase 3
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Bladder CancerEndometriosisInterstitial Cystitis+4 more
Centre Hospitalier Universitaire Vaudois232 enrolled4 locationsNCT05726786
Not Yet Recruiting
Phase 3
Comparatve study between self catheterisation with a silicone catheter and a stainless steel catheter assessing bladder infection rate in female patients who are self catheterising.
Neurogenic bladder with post void residual volumes of greater than 100mls
Dr LJ (Vic) du Plessis50 enrolled1 locationACTRN12611000344998